Comparative Study to Assess the Ongoing Pregnancy Rate for Poor Responders Women Undergoing Different Embryo Transfer Protocols
A Prospective, Four Arms, Open Label, Comparative Study to Assess the Ongoing Pregnancy Rate for Poor Responders Women Undergoing Different Embryo Transfer Protocols
1 other identifier
observational
291
1 country
1
Brief Summary
Published data on sequential transfer are limited and are not consistent. Also, further research into methods of risk combination and assessment, would allow us to help our patients make better-informed decisions about whether or not to proceed with invasive diagnostic tests as the PGS. So our study aims to describe the ongoing pregnancy rate for poor responders women undergoing four different embryo transfer protocols among four arms within the study. Moreover, to describe the miscarriage rate, and the baseline characteristics for the same population. This clinical study will be conducted in compliance with the clinical study protocol and applicable regulatory requirements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2021
CompletedFirst Posted
Study publicly available on registry
August 20, 2021
CompletedStudy Start
First participant enrolled
September 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 12, 2024
CompletedJuly 28, 2025
July 1, 2025
2.1 years
August 14, 2021
July 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ongoing pregnancy rate for poor responders women in the four arms
Recording the following for the four arms of the study: * Presence of intrauterine gestational sac at 12 weeks beyond embryo transfer * Presence of fetal heart pulsation at 12 weeks beyond embryo transfer
Till the end of 12 weeks of gestation
Secondary Outcomes (2)
miscarriage rate for poor responders women in the four arms
Till the end of 20 weeks of gestation
The baseline characteristics of the study participants
Before study intervention of the four arms (at day 2 in the ovulation induction cycle)
Study Arms (4)
Arm 1
Poor responders women undergoing frozen sequential embryo transfer on Day 3 and Day 5
Arm 2
Poor responders women undergoing sequential fresh embryo transfer on Day 3 and Day 5
Arm 3
Poor responders women undergoing sequential embryo transfer on Day 3 and Day 5 after performing PGS
Arm 4
Poor responders women undergoing conventional frozen embryo transfer on Day 5
Interventions
1. Sequential embryo transfer on day 3 and day 5 in a frozen cycle 2. Sequential embryo transfer on day 3 and day 5 in a fresh cycle 3. Sequential embryo transfer on day 3 and day 5 after performing PGS 4. Conventional Day 5 frozen embryo transfer
Eligibility Criteria
Poor responders women undergoing one of the following: 1. Sequential embryo transfer on day 3 and day 5 in a frozen cycle 2. Sequential embryo transfer on day 3 and day 5 in a fresh cycle 3. Sequential embryo transfer on day 3 and day 5 after performing PGS 4. Conventional Day 5 frozen embryo transfer
You may qualify if:
- The age group of these women is 25-45 years
- Normal endometrial cavity confirmed by hysteroscopy
- Poor responders with AMH \<1
- Patients with at least grade 1 days 3 embryo and grade 1 day 5 frozen embryos
You may not qualify if:
- Patients with any immunological disorders
- Patients with uncontrolled systemic diseases
- Patients with previous uterine surgeries except for Cesarean section
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wael Elbanna Cliniclead
- National Research Centre, Egyptcollaborator
Study Sites (1)
Wael Elbanna Clinic
Cairo, Egypt
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Managing director for Wael Elbanna Clinic
Study Record Dates
First Submitted
August 14, 2021
First Posted
August 20, 2021
Study Start
September 10, 2021
Primary Completion
October 20, 2023
Study Completion
November 12, 2024
Last Updated
July 28, 2025
Record last verified: 2025-07